1'-[2-(1,3-thiazol-2-yl)-3,4-dihydro-1,2-benzothiazin-6-yl]spiro[1H-2-benzofuran-3,4'-piperidine]

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻嗪类
• 英文名称: 1'-[2-(1,3-thiazol-2-yl)-3,4-dihydro-1,2-benzothiazin-6-yl]spiro[1H-2-benzofuran-3,4'-piperidine]
• 化学式: C₂₃H₂₃N₃OS₂
• 分子量: 421.6
• InChiKey: KALXJHACZWFJOP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  29
• 可旋转键数：
  2
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.35
• 拓扑面积：
  82.1
• 氢给体数：
  0
• 氢受体数：
  6

文献信息

• CYCLIC SULFONAMIDES AS SODIUM CHANNEL BLOCKERS
  申请人：Purdue Pharma LP

  公开号：EP2935257A1

  公开（公告）日：2015-10-28
• [EN] CYCLIC SULFONAMIDES AS SODIUM CHANNEL BLOCKERS<br/>[FR] SULFONAMIDES CYCLIQUES EN TANT QUE BLOQUANTS DES CANAUX SODIQUES
  申请人：PURDUE PHARMA LP

  公开号：WO2014096941A1

  公开（公告）日：2014-06-26

  The present disclosure provides cyclic sulfonamides of Formula (I), and the pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3a, R3b, and n are defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula (I) to treat a disorder responsive to the blockade of sodium channels. For example, compounds of the present disclosure are useful for treating pain.